Anatomical variations in coronary venous drainage: Challenges and solutions in delivering cardiac resynchronization therapy.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
06 2022
Historique:
revised: 20 04 2022
received: 21 02 2022
accepted: 03 05 2022
pubmed: 8 5 2022
medline: 10 6 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

To investigate the abnormalities of the coronary venous system in candidates for cardiac resynchronization therapy (CRT) and describe methods for circumventing the resulting difficulties. From four implanting institutes, data of all CRT implants between October 2008 and October 2020 were screened for abnormal cardiac venous anatomy, defined as an anatomical variation not conforming to the accepted 'normal' anatomy. Patient demographics, procedural detail, and subsequent left ventricle (LV) lead pacing indices were collected. From a total of 3548 CRT implants, 15 (0.42%) patients (80% male) of 72.2 ± 10.6 years in age with an LV ejection fraction of 34 ± 10.3% were identified to have had an abnormal cardiac venous anatomy over the study period. There were 13 cases of persistent left side superior vena cava (pLSVC), five of which had coronary sinus ostium atresia (CSOA) including two with an "unroofed" coronary sinus (CS); one patient had a unique anomalous origin of the CS and one patient had an isolated CSOA. In total 14 patients (60% repeat attempt) had successful percutaneous implant under general anesthesia (46.7%) via the cephalic vein (59.1%), using the femoral approach (53.3%) for levophase venography and/or pull-through, including one case of endocardial LV implant. Pacing follow-up over 37.64 ± 37.6 months demonstrated LV lead threshold between 0.62 and 2.9 volts (pulsewidth 0.4-1.5 ms) in all cases; five patients died within 2.92 ± 1.6 years of a successful implant. CRT devices can be implanted percutaneously even in the presence of substantial abnormalities of coronary venous anatomy. Alternative routes of venous access may be required.

Identifiants

pubmed: 35524414
doi: 10.1111/jce.15524
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1262-1271

Subventions

Organisme : Abbott Medical

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845-1853.
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150.
Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329-1338.
Gamble JHP, Herring N, Ginks M, Rajappan K, Bashir Y, Betts TR. Procedural success of left ventricular lead placement for cardiac resynchronization therapy. JACC Clin Electrophysiol. 2016;2(1):69-77.
Pieri M, Belletti A, Monaco F, et al. Outcome of cardiac surgery in patients with low preoperative ejection fraction. BMC Anesthesiol. 2016;16(1):97.
Schummer W, Schummer C, Fröber R. Persistent left superior vena cava and central venous catheter position: clinical impact illustrated by four cases. Surg Radiol Anat. 2003;25(3-4):315-321.
Ussen B, Dhillon PS, Anderson L, Beeton I, Hickman M, Gallagher MM. Safety and feasibility of cephalic venous access for cardiac resynchronization device implantation. Pacing Clin Electrophysiol PACE. 2011;34(3):365-369.
Gonna H, Domenichini G, Zuberi Z, et al. Femoral implantation and pull through as an adjunct to traditional methods in cardiac resynchronization therapy. Heart Rhythm. 2016;13(6):1260-1265.
Dhillon PS, Gallagher MM. Femoral vein implantation with subclavian vein pullthrough for left ventricular lead placement. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2010;12(8):1193-1194.
Zou F, Worley SJ, Steen T, et al. The combination of coronary sinus ostial atresia/abnormalities and a small persistent left superior vena cava-Opportunity for left ventricular lead implantation and unrecognized source of thromboembolic stroke. Heart Rhythm. 2021;18(7):1064-1073.
Worley SJ. Challenging implants require tools and techniques not tips and tricks. Card Electrophysiol Clin. 2019;11(1):75-87.
Yi F, Wu F, Shen M, et al. Coronary vein angioplasty to facilitate implantation of left ventricular lead. Europace. 2010;12(11):1600-1603.
Akhtar Z, Chen Z, Leung LWM, Beeton I, Gallagher MM. Innovative cardiac resynchronization. JACC Case Rep. 2021;3(4):594-596.
Worley SJ. How to use balloons as anchors to facilitate cannulation of the coronary sinus left ventricular lead placement and to regain lost coronary sinus or target vein access. Heart Rhythm. 2009;6(8):1242-1246.
Akhtar Z, Harding I, Elbatran AI, et al. Multi-lead cephalic venous access and long-term performance of high-voltage leads. J Cardiovasc Electrophysiol. 2021;32(4):1131-1139.
Biffi M, Boriani G, Frabetti L, Bronzetti G, Branzi A. Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation. Chest. 2001;120(1):139-144.
Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of Marshall: a therapeutic opportunity in atrial fibrillation. Heart Rhythm. 2016;13(2):593-601.
Worley SJ, Gohn DC, Pulliam RW. Interventional approach to CRT in a patient with drainage of the superior vena cava into the coronary sinus. Pacing Clin Electrophysiol. 2008;31(4):506-508.
van Gelder BM, Houthuizen P, Bracke FA. Transseptal left ventricular endocardial pacing: preliminary experience from a femoral approach with subclavian pull-through. Europace. 2011;13(10):1454-1458.
Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206-1214.
Graham AJ, Providenica R, Honarbakhsh S, et al. Systematic review and meta-analysis of left ventricular endocardial pacing in advanced heart failure: Clinically efficacious but at what cost? Pacing Clin Electrophysiol. 2018;41(4):353-361.
Salminen JT, Hakala T, Pihkala J, Mattila I, Puntila J, Sairanen H. Coronary sinus orifice atresia with left superior vena cava in patients with univentricular heart. Ann Thorac Surg. 2006;81(5):e16-e17.

Auteurs

Zaki Akhtar (Z)

Department of Cardiology, St George's University Hospital, London, UK.
Department of Cardiology, Ashford and St Peter's Hospital, Surrey, UK.

Manav Sohal (M)

Department of Cardiology, St George's University Hospital, London, UK.

Christos Kontogiannis (C)

Department of Cardiology, St George's University Hospital, London, UK.

Idris Harding (I)

Department of Cardiology, St George's University Hospital, London, UK.

Zia Zuberi (Z)

Department of Cardiology, St George's University Hospital, London, UK.
Department of Cardiology, Royal Surrey County Hospital, Guildford, UK.

Abhay Bajpai (A)

Department of Cardiology, St George's University Hospital, London, UK.

Mark Norman (M)

Department of Cardiology, St George's University Hospital, London, UK.
Department of Cardiology, Frimley Park Hospital, Surrey, UK.

Simon Pearse (S)

Department of Cardiology, St George's University Hospital, London, UK.

Ian Beeton (I)

Department of Cardiology, Ashford and St Peter's Hospital, Surrey, UK.

Mark M Gallagher (MM)

Department of Cardiology, St George's University Hospital, London, UK.
Department of Cardiology, Ashford and St Peter's Hospital, Surrey, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH